Company: Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated : [VRTX
Loading...
()
]
]Nov.02
12:32 PM ET
Monday, 2 Nov 2009
Over the past few days there's been a remarkable confluence of newsflow, most of it positive, out of biopharma. First the bad news. Read More
Topics:CEOs and CFOs | Stock Market | Medicine | Corporate News | Pharmaceuticals
Oct.22
7:26 AM ET
Thursday, 22 Oct 2009
There’s still a week-and-a-half left in the month, but the markets are currently maintaining yet another month of gains. Read More
Topics:Nasdaq | Dow Jones Industrial Average | Stock Market
Companies:MBIA Inc | MetroPCS Communications Inc. | Marshall & Ilsley Corp | Boston Scientific Corp | Interpublic Group of Companies Inc | Cerner Corporation | Joy Global Inc. | Autodesk Inc | Vertex Pharmaceuticals Incorporated | Wynn Resorts, Limited | NVIDIA Corporation | Comcast Corp | Genzyme Corp | Peabody Energy Corp | Moody's Corp | SLM Corporation | Harley Davidson Inc | Lexmark International Inc | Boeing Co | General Electric | Verizon Communications | The Travelers Companies, Inc | Walt Disney Co | Exxon Mobil Corp | United Technologies Corp | Chevron Corp | Caterpillar Inc | Google Inc | Apple Inc
Sep.30
6:35 PM ET
Wednesday, 30 Sep 2009
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now! Read More
Topics:Stock Market | Stock Picks
Jun.11
10:41 AM ET
Thursday, 11 Jun 2009
Dr. Mark Monane, senior biotech analyst at Needham & Co., named some biotech stocks that look attractive. Read More
Topics:Investment Strategy | Nasdaq | NYSE | Stock Market | Stock Options | Stock Picks
VIDEO | COMPANIES : Vertex Pharmaceuticals Incorporated
Protection of intellectual property rights in China has improved in the last few years, says Steve Yang, vice president ...
Larry Nusbaum, of the Vertex Fund, and Adam Bold, of the Mutual Fund Store, discuss whether stocks will sell off if the ...
A new study is putting Merck's cholesterol drugs under pressure today, reports CNBC's Mike Huckman, with Ken Frazier, Me...
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.
Diabetes is a global epidemic that presents an estimated $25 billion drug and device market and some predict that number...
More VideosNews |
COMPANY : Vertex
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
Partners: AOL Money | BloggingStocks.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal
